Allogeneic Hematopoietic Cell Transplantation (HCT) Improves Immune Deficiency/Dysregulation with Low Toxicity in Patients with Partial RAG Deficiency

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Dimana Dimitrova, Luigi Daniele Notarangelo, Jessenia Campos, Amy Chai, Alison Christina Cusmano, Ottavia M. Delmonte, Esther Kang, Mustafa A Hyder, Ralph Mangusan, Katherine Myint‐Hpu, Kamil A. Rechache, Ruby Sabina
+6 more Anahita Agharahimi, Jenna Bergerson, Alexandra F. Freeman, Steven M. Holland, Christopher George Kanakry, Jennifer Ann Kanakry
DOI: 10.1016/j.jtct.2025.12.177
Cited by: 0

Fields of Study & Subjects

Immunodeficiency and Autoimmune Disorders Hematopoietic Stem Cell Transplantation Transplantation: Methods and Outcomes

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S122–S122
Publication date
1 February 2026
Language
EN